Antibody to Epstein-Barr virus-specific DNase as a marker for the early detection of nasopharyngeal carcinoma
β Scribed by Jen-Yang Chen; Mei-Ying Liu; Chien-Jen Chen; Mow-Ming Hsu; Shih-Mien Tu; Hong-Hsin Lee; Shiow-Ling Kuo; Czau-Siung Yang
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 180 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
We have previously shown that high levels of antibody to Epstein-Barr virus (EBV)-specific DNase may be a useful marker for the early diagnosis of nasopharyngeal carcinoma (NPC). Sera from 3,368 males in an area with a high risk for the development of NPC were examined for the presence of antibody to EBV-specific DNase activity. Significant levels of the antibody were found in 430 of these sera. As a result, 32 individuals have attended the out-patient department of otolaryngology for clinical examination. Among them, one individual was found to have a stage II nasopharyngeal carcinoma. This result supports the value of determination of antibody to EBV-specific DNase as a marker for the early detection of NPC.
π SIMILAR VOLUMES
## Abstract We have examined serial sera from 17 juvenile patients with nasopharyngeal carcinoma (NPC) for their capacity to neutralize the activity of EpsteinβBarr virus (EBV)βspecific DNase. The results revealed that NPC patients who became longβterm survivors (LTS) without evidence of the diseas
Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) generally occurs in adults, especially in high-prevalence populations such as the Chinese and Eskimos. In Maghrebian populations, young patients affected with this malignancy represent 25% of the total NPC cases. In adults with NPC,
## Abstract Serological tests for EpsteinβBarr virus (EBV) have been used for many years as diagnostic predictors of nasopharyngeal carcinoma. It has been shown previously that the conventional immunofluorescence assay has a limited diagnostic value, especially in young patients from North African